Cancer is frequently associated with Inclusion Bod

Cancer is frequently associated with Inclusion Body Myositis. Some of the trademark biomarkers, associated with the condition, indicate that Leronlimab might help Peter Frampton. High CCR5 expression, T Cell deregulation, and chronic inflammation are present. Current treatment is immune suppressing steroids. I didn't see this in Ohm20's list. However, I may have an outdated copy.



https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374100/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516174/